13F reference period
Q2 2026
Security Snapshot
INOVIO PHARMACEUTICALS, INC. - COMMON STOCK (INO) Institutional Ownership
CUSIP: 45773H409
13F Institutional Holders and Ownership History from Q4 2023 to Q3 2026
Institutions Reporting
100
Shares (Excl. Options)
32.81M
Full value: 32,809,351 · shares · 30 Jun 2026Price
$1.10
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COMMON STOCK
- Symbol
- INO on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 32,809,351
- Total 13F value
- $36,119,103
- Portfolio coverage rank
- 0%
- Share change
- -391,725
- Value change
- -$1,703,781
- Number of holders
- 100
- Shares outstanding
- 105,959,345
- SEC-reported price per share
- $1.00
- Insider filing price
- $1.00
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- INO - INOVIO PHARMACEUTICALS, INC. - COMMON STOCK is tracked under CUSIP 45773H409.
- 100 institutions reported positions in Q2 2026.
- 11 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 98 to 100 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$54.59M
Full value: $54,590,692 · USD · 31 Mar 2026.$36.12M
Full value: $36,119,103 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 100 institutions filings for Q2 2026.
Security key
45773H409
13F reference period
Q2 2026
13F holders
100
13D/G owners
11
CIK / CUSIP context first
Open Q2 2026 holders
INO full holder history
INOVIO PHARMACEUTICALS, INC. SEC filings
INOVIO PHARMACEUTICALS, INC. company facts
INOVIO PHARMACEUTICALS, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 45773H409:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
11
Security
INO
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 14% | +42% | $15,364,105 | +$6,909,308 | 15,364,105 | +82% | FMR LLC | 30 Sep 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 9.9% | $12,373,167 | 10,666,523 | RA Capital Management, L.P. | 31 Jul 2026 | |||
| JANUS HENDERSON GROUP PLC | 10% | +63% | $12,999,275 | +$6,630,068 | 6,666,295 | +104% | JANUS HENDERSON GROUP PLC | 28 Nov 2025 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 8.2% | -11% | $6,995,237 | +$2,889,570 | 6,190,475 | +70% | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5% | $4,827,417 | 4,161,566 | Vanguard Capital Management | 30 Jun 2026 | |||
| Alyeska Investment Group, L.P. | 6% | -19% | $6,400,000 | 4,000,000 | 0% | Alyeska Investment Group, L.P. | 31 Dec 2025 | |
| Adage Capital Management, L.P. | 4% | -31% | $3,977,142 | -$933,751 | 3,428,571 | -19% | Adage Capital Management, L.P. | 30 Jun 2026 |
| VANGUARD GROUP INC | 5% | -9.5% | $5,769,107 | +$2,238,719 | 3,315,579 | +63% | The Vanguard Group | 31 Dec 2025 |
| Stonepine Capital Management, LLC | 3.8% | -28% | $2,683,444 | -$900,721 | 1,434,997 | -25% | Stonepine Capital Management, LLC | 31 Mar 2025 |
| Deep Track Capital, LP | 2.4% | $3,076,623 | 1,314,796 | Deep Track Capital, LP | 30 Sep 2025 | |||
| BlackRock, Inc. | 1.5% | -80% | $1,099,608 | -$3,642,379 | 537,627 | -77% | BlackRock, Inc. | 30 Jun 2025 |
As of 30 Jun 2026,
100
institutional investors reported holding
shares of
INOVIO PHARMACEUTICALS, INC. - COMMON STOCK (INO).
This represents
31%
of the company’s total
outstanding shares.
32.81M
Full value: 32,809,351 · shares · 30 Jun 2026105.96M
Full value: 105,959,345 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
30%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 8% | 8,454,797 | -9.5% | 0% | $9,300,277 |
| Jupiter Topco LLC | 4.9% | 5,171,053 | 0% | 0% | $5,714,014 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.4% | 3,650,562 | +26% | 0% | $4,015,618 |
| Boxer Capital Management, LLC | 2.7% | 2,844,994 | +20% | 0.24% | $3,129,493 |
| ADAR1 Capital Management, LLC | 2% | 2,143,910 | +46% | 0.11% | $2,358,301 |
| D. E. Shaw & Co., Inc. | 1.3% | 1,351,656 | -39% | 0% | $1,486,822 |
| TWO SIGMA INVESTMENTS, LP | 1.2% | 1,239,778 | +218% | 0% | $1,363,756 |
| Eversept Partners, LP | 0.98% | 1,035,360 | 0% | 0.06% | $1,138,896 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.76% | 802,751 | +0.16% | 0% | $883,749 |
| MILLENNIUM MANAGEMENT LLC | 0.75% | 796,107 | -44% | 0% | $875,718 |
| BlackRock, Inc. | 0.74% | 779,057 | +18% | 0% | $856,963 |
| VANGUARD FIDUCIARY TRUST CO | 0.45% | 480,769 | +23% | 0% | $528,846 |
| Caption Management, LLC | 0.45% | 478,950 | 0.02% | $526,845 | |
| RENAISSANCE TECHNOLOGIES LLC | 0.34% | 361,339 | -44% | 0% | $397,473 |
| STATE STREET CORP | 0.32% | 336,610 | +14% | 0% | $370,271 |
| GSA CAPITAL PARTNERS LLP | 0.25% | 265,011 | -0.02% | 0.02% | $292,000 |
| UBS Group AG | 0.25% | 262,320 | +5.1% | 0% | $288,552 |
| Quadrature Capital Ltd | 0.24% | 258,928 | 0% | $284,821 | |
| CITADEL ADVISORS LLC | 0.23% | 241,775 | -16% | 0% | $265,952 |
| NORTHERN TRUST CORP | 0.16% | 174,394 | -42% | 0% | $191,833 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.16% | 173,000 | 0% | 0% | $190,300 |
| NOMURA HOLDINGS INC | 0.14% | 150,000 | 0% | $165,000 | |
| HRT FINANCIAL LP | 0.13% | 140,432 | +987% | 0% | $154,000 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 0.13% | 133,648 | 0% | $147,012 | |
| GMT Capital Corp | 0.12% | 126,119 | 0% | 0.01% | $138,731 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
12
Headline period
Q2 2026
Rows shown
1-12 of 12
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 364,015 | $438,492 | +$280,969 | $1.22 | 29 |
| 2026 Q2 | 32,809,351 | $36,119,103 | -$1,703,781 | $1.10 | 100 |
| 2026 Q1 | 31,364,859 | $54,590,692 | -$2,795,850 | $1.74 | 98 |
| 2025 Q4 | 33,075,777 | $57,545,745 | +$21,224,322 | $1.74 | 100 |
| 2025 Q3 | 20,711,886 | $48,449,935 | +$25,433,512 | $2.34 | 98 |
| 2025 Q2 | 10,168,502 | $20,694,831 | -$6,577,397 | $2.04 | 101 |
| 2025 Q1 | 13,600,161 | $22,159,691 | +$51,992 | $1.63 | 105 |
| 2024 Q4 | 13,346,624 | $24,424,740 | +$7,463,553 | $1.83 | 100 |
| 2024 Q3 | 8,566,045 | $49,511,575 | +$2,096,827 | $5.78 | 95 |
| 2024 Q2 | 8,056,972 | $65,100,837 | +$29,640,224 | $8.08 | 92 |
| 2024 Q1 | 4,044,287 | $56,123,192 | +$53,680,856 | $13.88 | 83 |
| 2023 Q4 | 298,900 | $152,940 | +$152,930 | $0.51 | 7 |